# Effect of Dapagliflozin on Body Weight in Overweight Women Consuming Different Proportions of Carbohydrate Diet.

> **NCT06383832** · PHASE4 · COMPLETED · sponsor: **Sun Jia** · enrollment: 36 (actual)

## Conditions studied

- Overweight
- Carbohydrate
- Sodium-glucose Transporter 2 Inhibitors

## Interventions

- **DRUG:** Dapagliflozin

## Key facts

- **NCT ID:** NCT06383832
- **Lead sponsor:** Sun Jia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-28
- **Primary completion:** 2023-12-26
- **Final completion:** 2023-12-26
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2024-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06383832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06383832, "Effect of Dapagliflozin on Body Weight in Overweight Women Consuming Different Proportions of Carbohydrate Diet.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06383832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*